| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021219089-A1 | Sars-cov-2 inhibitors having covalent modifications for treating coronavirus infections | 2020-04-30 |
| WO-2020248864-A1 | Passivator, passivation method therefor and method for preparing semiconductor film | 2019-06-12 |
| US-2020206216-A1 | Inhibitors of fibroblast activation protein | 2018-12-21 |
| CN-113811529-A | Fibroblast activation protein inhibitor | 2018-12-21 |
| US-2020078364-A1 | Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety | 2018-09-11 |
| BR-112021004371-A2 | therapy in combination with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety | 2018-09-11 |
| CN-113164466-A | Combination therapy using phosphoinositide 3-kinase inhibitors having zinc binding moieties | 2018-09-11 |
| IL-281303-D0 | Combination therapy with 3-kinase phosphonocyte inhibitors with half zinc linker | 2018-09-11 |
| KR-20210087438-A | Combination therapy with phosphoinositide 3-kinase inhibitors with zinc binding moieties | 2018-09-11 |
| JP-2022500374-A | Combination therapy with phosphoinositide 3-kinase inhibitors with zinc binding moieties | 2018-09-11 |
